|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Efficacy and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early Her2-positive breast cancer (NeoSphere): a randomised multicentre, open-label, phase 2 trial显示文摘 | Gianni L Pienkowski T Im YH | 2012 | Lancet Oncol2012，13，1： | 1 |
| 2 | Efficacy and safety of neoadju-vant pertuzumab and trastuzumab in women with locally advanced,in-flammatory,or early HER2-positive breast cancer(NeoSphere):a ran-domised multicentre,open-label,phase 2 trial显示文摘 | Gianni L Pienkowski T Im YH | | 0，，： | 1 |
| 3 | Thoracic manifestation of ChurgStrauss syndrome:radiologic and clinical findings显示文摘 | Choi YH Im JG Han BK | 2000 | Chest2000，117，1： | 1 |
| 4 | Efficacy and safety of neoad-juvant pertuzumab and trastuzumab in women with locally ad-vanced, inflammatory, or early HER2-positive breast cancer (Neo-Sphere): a randomised multicentre, open-label, phase 2 trial显示文摘 | Gianni L Pienkowski T Im YH | 2012 | Lan-cet Oncol2012，13，1： | 1 |
| 5 | Efficacy and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early HER2-positive breast cancer (NeoSphere): a randomised multicentre, open-label, phase 2 trial显示文摘 | Gianni L Pienkowski T Im YH | 2012 | Lancet Oncol2012，13，1： | 1 |
| 6 | The anatomy of the pericardial space:a study in cadavers and patients显示文摘 | Choe YH Im JG Park JH Han MC | 1987 | AJR1987，149，4： | 1 |
| 7 | Efficacy and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced,inflammatory,or early HER2-positive breast cancer (NeoSphere):a randomised multicentre,open-label,phase 2 trial显示文摘 | Gianni L Pienkowski T Im YH | | 0，，01： | 1 |
| 8 | Decreased blood perfusion in temporal lobe in transient global amnesia显示文摘 | Chang YH Jang IM Baek MJ | 2010 | Alzheimers Dement2010，6，： | 1 |
| 9 | Efficacy and safety of neoadju- vant pertuzumab and trastuzumab in women with locally advanced,in- flammatory, or early her2-positive breast cancer ( neosphere ) : A ran- domised muhicentre, open-label, phase 2 trial 显示文摘 | Gianni L Pienkowski T Im YH | 2012 | Lancet Oncol2012，13，1： | 1 |
| 10 | Loss of transforming growth factor beta signalling in the intestine contributes to tisse injury in inflammatory bowel disease显示文摘 | Hahm KB Im YH Parks TW | 2001 | Gut2001，49，2： | 1 |
| 11 | US of mammographycally detected clustered microcalification显示文摘 | MOON W K IM J G KOH YH | 2000 | Radiology2000，217，： | 1 |
| 12 | Adjuvant chemotherapy with 5-fluorouracil and cisplatin in lymph node-positive tho-racic esophageal squamous cell carcinoma显示文摘 | Lee J Lee KE Im YH | 2005 | Ann Thorac Surg2005，80，4： | 1 |
| 13 | Efficacy and safety of neoad-juvant pertuzumab and trastuzumab in women with locally ad-vanced, inflammatory, or early HER2-positive breast cancer (Neo-Sphere): a randomised multicentre, open-label, phase 2 trial显示文摘 | Gianni L Pienkowski T Im YH | 2012 | Lan-cet Oncol2012，13，1： | 1 |
| 14 | Genetic polymorphisms of SLC28A3,SLC29A1 and RRM1 predict clinical outcome in patients with metastatic breast cancer receiving gemcitabine plus paclitaxel chemotherapy显示文摘 | Lee SY Im SA Park YH | 2014 | Eur J Cancer2014，50，4： | 1 |
| 15 | Efficacy and safety of neoadjuvant pertuzumab and trastuzumab in women withlocally advanced, inflammatory, or early HER2- positive breast cancer (NeoSphere) : a randomised multicentre, open - label, phase 2 trial显示文摘 | GIANNI L PIENKOWSKI T IM YH | 2012 | Lancet Oncol2012，13，1： | 1 |
| 16 | Evaluation of ER and Ki-67 prolif- eration index as prognostic factors for survival following neoadju- vant chemotherapy with doxorubicin/docetaxel for locally advancedbreast cancer显示文摘 | Lee J Im YH Lee SH | 2008 | Cancer Chemother Pharmacol2008，61，4： | 1 |
| 17 | Efficacy and safety of neo- adjuvant pertuzumab and trastuzumab in women with locally ad- vanced, inflammatory, or early HER2-positive breast cancer ( Neo- Sphere) : a randomised multicentre, open-label, phase 2 trial 显示文摘 | Gianni L Pieukowski T Im YH | 2012 | Lancet Onco12012，13，： | 1 |
| 18 | Loss of TGF - re signaling contributes to autoimmune pancreatitis 显示文摘 | Hahm KB Im YH Lee C | 2000 | J Clin Invest2000，105，8： | 1 |
| 19 | Phase Ⅲ, multicenter, randomized trial of maintenance chemotherapy versus observation in patients with metastatic breast cancer after achieving disease control with six cycles of gemcitabine plus paclitaxel as first-line chemotherapy: KCSG-BR07-02 显示文摘 | Park YH Jung KH Im SA | 2013 | J Clin Oncol2013，31，： | 1 |
| 20 | TreaUment of thoracic multiloculated empyemas with intracavitary urokinase: a prospective study 显示文摘 | Lee KS Im JG Kim YH | 1991 | Radiology1991，179，7： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员